Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
2.370
-0.040 (-1.66%)
At close: Dec 5, 2025, 4:00 PM EST
2.469
+0.099 (4.19%)
After-hours: Dec 5, 2025, 7:35 PM EST
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $74.79 million as of December 5, 2025. Its market cap has decreased by -62.35% in one year.
Market Cap
74.79M
Enterprise Value
-51.48M
1-Year Change
-62.35%
Ranking
Category
Stock Price
$2.37
Market Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $74.79M, a decrease of -68.19%. That is a compound annual growth rate of -31.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 74.79M | -60.10% |
| Dec 31, 2024 | 187.44M | 71.66% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.55B |
| Johnson & Johnson | 490.70B |
| AbbVie | 405.35B |
| UnitedHealth Group | 302.81B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.24B |
| Abbott Laboratories | 216.87B |